The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

Regional Differences in Hospitalizations among Patients Admitted with Chronic Obstructive Pulmonary Disease

Authors: Alhareth Alsagban, MD, Scott Mitchell Wright, MD, Che’ Matthew Harris, MD

Abstract

Objective: Extreme temperatures negatively impact pulmonary function. This study explored whether the variability in ambient temperatures across disparate geographic regions in the United States was associated with differences in hospital outcomes for patients admitted with chronic obstructive pulmonary disease (COPD).

Methods: Using the 2016–2019 National Inpatient Sample database, we compared adults hospitalized with COPD in the US Northeast with those in the US South. We conducted multivariable regression analyses to study outcomes, including mortality, resource utilization, and posthospital discharge disposition.

Results: From 2016 to 2019, 463,830 (30.1%) patients were admitted with COPD in the Northeast and 1,078,930 (69.9%) in the South. The lowest hospitalization rates for COPD were observed in both regions during the hottest months (July and August). Those in the Northeast had higher adjusted odds of in-hospital mortality (adjusted odds ratio: 1.1 [95% confidence interval {CI} 1.0–1.2]; P = 0.03) and a lower likelihood of being discharged to home after the hospitalizations (adjusted odds ratio: 0.63 [95% CI 0.61–0.65]; P < 0.01]) compared with patients hospitalized in the South. Patients in the Northeast had longer hospital stays (adjusted mean difference: +0.19 days; 95% CI 0.13–0.25; P < 0.01) and incurred greater hospital charges compared with patients in the South (adjusted mean difference: $3728; 95% CI 1840–5616; P < 0.01).

Conclusions: Patients hospitalized with COPD in the Northeast had worse clinical outcomes and greater resource utilization than in the South. These findings, coupled with the higher admission rates during colder months, raise questions about the influence of colder ambient temperatures on COPD exacerbations.
Posted in: Pulmonary Disease25

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Centers for Disease Control and Prevention. Leading Causes of Death. Accessed January 21, 2025. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm.
 
2. Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010. COPD J Chronic Obstr Pulm Dis. 2017;14(1):72–79. doi: 10.1080/15412555.2016.1199669.
 
3. Singh JA, Yu S. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respir Res. 2016; 17(1):1. doi:10.1186/s12931-015-0319-y.
 
4. Mannino DM, Roberts MH, Mapel DW, et al. National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029. CHEST. 2024;165(5):1093–1106. doi:10.1016/j.chest.2023.11.040.
 
5. McCormack MC, Paulin LM, Gummerson CE, et al. Eur Respir J. 2017;49(6):1601501. doi: 10.1183/13993003.01501-2016.
 
6. Scheerens C, Nurhussien L, Aglan A, et al. The impact of personal and outdoor temperature exposure during cold and warm seasons on lung function and respiratory symptoms in COPD. ERJ Open Res. 2022;8(1):00574–02021. doi:10.1183/23120541.00574-2021.
 
7. De Miguel-Díez J, Hernández-Vázquez J, López-de-Andrés A, et al. Analysis of environmental risk factors for chronic obstructive pulmonary disease exacerbation: A case-crossover study (2004-2013). Larcombe A, ed. PLOS ONE. 2019;14(5):e0217143. doi:10.1371/journal.pone.0217143.
 
8. Agency for Healthcare Research And Quality. Healthcare Cost & Utilization Project. Overview of the National (Nationwide) Inpatient Sample (NIS). Accessed January 31, 2025. https://hcup-us.ahrq.gov/nisoverview.jsp.
 
9. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity Measures for Use with Administrative Data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-00004.
 
10. Tran HM, Tsai FJ, Lee KY, et al. Extreme temperature increases the risk of COPD morbimortality: A systematic review and meta-analysis. Sci Total Environ. 2025;958:178087. doi:10.1016/j.scitotenv.2024.178087.
 
11. Almagro P, Hernandez C, Martinez-Camblor P, et al. Seasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan area.Int J Chron Obstruct Pulmon Dis. Published online May 2015:899. doi:10.2147/COPD.S75710.
 
12. Rinne ST, Graves MC, Bastian LA, et al. Association between length of stay and readmission for COPD. Am J Manag Care. 2017;23(8):e253–e258.
 
13. Holguin F, Folch E, Redd SC, et al. Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001. Chest. 2005;128(4):2005–2011. doi:10.1378/chest.128.4.2005